Notícias e Atividades da Kiniksa Pharmaceuticals

Kiniksa Pharmaceuticals é uma das ...

• Russell 3000;
• TOB Iconic 10,000.

Kiniksa Pharmaceuticals é uma empresa listada sob o símbolo KNSA (US).

Veja o organograma con seus 26 executivos principais

Biografias mais buscadas da Kiniksa Pharmaceuticals

• Sanj Patel, Chairman of the Board and Chief Executive Officer
• Tracey McCain, Director
• Barry Quart, Director

Recentes movimentos de executivos em Kiniksa Pharmaceuticals

• Cantey Boyd, ingressou na Companhia como Director  (Notícia publicada em 9 de outubro de 2024).

Criar um alerta
para seguir os movimentos de executivos da Kiniksa Pharmaceuticals.

Kiniksa Pharmaceuticals possui 1.830 concorrentes concorrentes Pfizer (Estados Unidos), Sanofi (França) e Eli Lilly (Estados Unidos).

Popular M&A news in Farmacêutica

• Chimerix and Chimerix have merged  (publicado em 22 de abril de 2025)..
• Imbria Pharmaceuticals acaba de anunciar uma arrecadação de fundos de 58 milhões de dólares. (publicado em 10 de abril de 2025).
• Clario adquiriu NRx Pharmaceuticals (publicado em 18 de março de 2025).

Outros contatos sugeridos na indústria do Farmacêutica

• Estelle Vester-Blokland - Senior Vice President, Medical and Head, International Markets da Bristol-Myers Squibb
• Kristin Berkinsky - Chief Human Resources Officer da Adare Pharmaceuticals
• Seth Harrison - Chairman and Director da Braeburn Pharmaceuticals

Saiba mais sobre a indústria do Farmacêutica

Últimos comunicados de imprensa de Kiniksa Pharmaceuticals

• Kiniksa Pharmaceuticals to Present at 2022 Wedbush PacGrow Healthcare Conference | Kiniksa Pharmaceuticals
• Kiniksa Pharmaceuticals Announces Global License Agreement with Genentech for Vixarelimab | Kiniksa Pharmaceuticals
• Kiniksa Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update | Kiniksa Pharmaceuticals
• Kiniksa Pharmaceuticals to Report Second Quarter 2022 Financial Results on August 3, 2022 | Kiniksa Pharmaceuticals
• Kiniksa Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate Update | Kiniksa Pharmaceuticals
• Kiniksa Pharmaceuticals to Report First Quarter 2022 Financial Results on May 3, 2022 | Kiniksa Pharmaceuticals
• Kiniksa Pharmaceuticals to Present at 2021 Cantor Fitzgerald Virtual Global Healthcare Conference | Kiniksa Pharmaceuticals
• Kiniksa Announces Launch of ARCALYST Named Patient Program | Kiniksa Pharmaceuticals
• Kiniksa Reports Second Quarter 2021 Financial Results and Recent Corporate and Portfolio Activity | Kiniksa Pharmaceuticals
• Kiniksa Pharmaceuticals to Present at 2021 Wedbush PacGrow Healthcare Conference | Kiniksa Pharmaceuticals
• View more press releases Close

Redes sociais sobre Kiniksa Pharmaceuticals

• Kiniksa Pharmaceuticals na Wikipedia, Google News e Yahoo Finance
• Kiniksa Pharmaceuticals na LinkedIn, Twitter e YouTube